By Conjoint Professor Tracey OBrien

Conference Abstracts

Mould EV; Lau L; Arndt G; Barahona P; Cowley MJ; Ekert P; Failes T; Fletcher J; Gifford A; Grebert-Wade D; Haber M; Kamili A; Kumar A; Lock RB; Marshall GM; Mayoh C; Norris M; O'Brien T; Quang DAK; Strong P; Sherstyuk A; Trahair T; Tsoli M; Tucker K; Warby M; Wong M; Xie J; Ziegler DS; Tyrrell V, 2019, 'Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Atlanta, GA, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-3111

Wakefield CE; Vetsch J; Tucker KM; Warby M; O'Brien T; Techakesari P; Glenn M; Trahair TN; Marron JM; Lau L; Tyrell V; Ziegler D, 2018, 'Families' and Healthcare Professionals' Hopes and Expectations Participating in a Precision Medicine Trial for Children with High-Risk Cancer: The PRISM-Impact Study', in PEDIATRIC BLOOD & CANCER, WILEY, Vol. 65, pp. S62 - S62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000445195000120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ekert P; Wong M; Mould E; Gifford A; Norris M; Warby M; Trahair T; Tucker K; Ziegler D; Marshall G; O'Brien T; Haber M; Vanessa T; Cowley M, 2018, 'Zero Childhood Cancer: A Comprehensive Precision Medicine Platform for Children with High-Risk Cancer', in PEDIATRIC BLOOD & CANCER, WILEY, Vol. 65, pp. S643 - S644, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000445195005221&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Robertson EG; Mitchell R; Wakefield CE; Lewis P; Cousens N; Marshall GM; Russell SJ; Ziegler DS; Anazodo A; Trahair TN; Barbaric D; Cohn RJ; Alvaro F; O'Brien TA, 2018, 'Enrolment in early phase paediatric oncology clinical trials: the healthcare professionals’ perspective.', Hong Kong, presented at International Psycho-Oncology Society, Hong Kong, 31 October 2018 - 02 November 2018

Mould E; Lau L; Arndt G; Barahona P; Cowley M; Ekert P; Failes T; Fletcher J; Gifford A; Haber M; Kamili A; Kumar A; Lock R; Marshall G; Mayoh C; Mead S; Norris M; O'Brien T; Pinese M; Quang DAK; Trahair T; Tsoli M; Tucker K; Warby M; Wong M; Xie J; Ziegler D; Tyrrell V, 2018, 'Abstract LB-138: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 78, pp. lb-138-lb-138, http://dx.doi.org/10.1158/1538-7445.am2018-lb-138

Vetsch J; Wakefield CE; Tucker K; Warby M; Techakesari P; Marshall G; Trahair TN; O'Brien T; Marron JM; Lau L; Tyrell V; Ziegler D, 2018, 'The PRISM-IMPACT study: What are the hopes and expectations of families and health care professionals enrolling in a personalised medicine trial for high risk childhood cancers?', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, ITALY, Milan, Vol. 27, pp. 690 - 691, presented at 51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), ITALY, Milan, 16 June 2018 - 19 June 2018

Dolnikov A; Xu N; Tse B; Shen S; O'Brien T, 2018, 'BROMODOMAIN INHIBITOR JQ1 MODULATES IMMUNE SUPPRESSIVE PATHWAYS IN NEUROBLASTOMA AND ENHANCES CARGD2T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Xu N; Tse B; O'Brien T, 2018, 'EPIGENETIC AGENT MODULATES TUMOUR MICROENVIRONMENT AND POTENTIATES CART CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Xu N; Tse B; Bishop D; Gottlieb D; Micklethwaite K; O'Brien T, 2018, 'FACTORS PROMOTING CD19-NEGATIVE RELAPSES FOLLOWING CAR19T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S8 - S8, http://dx.doi.org/10.1016/j.jcyt.2018.02.009

Tse B; Xu N; Bishop D; Gottlieb D; Micklethwaite K; O'Brien T; Dolnikov A, 2018, 'TUMOUR MICROENVIRONMENT MODULATES CART CELL FATE IN PAEDIATRIC LEUKEMIA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, http://dx.doi.org/10.1016/j.jcyt.2018.02.286

Robertson E; Wakefield C; Cohn R; O'Brien T; Ziegler D; Fardell J, 2018, 'The development of Delta: a decision aid to help parents considering enroling their child in a paediatric oncology clinical trial', in PSYCHO-ONCOLOGY, WILEY, Vol. 27, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000426522700019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chinnabhandar V; Tran S; Sutton R; Shaw PJ; Mechinaud F; Cole C; Tapp H; Teague L; Fraser C; O'Brien TA; Mitchell R, 2018, 'Use of Thiotepa in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: An Australian and New Zealand Children's Haematology/Oncology Group Study', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, Vol. 24, pp. S310 - S310, presented at Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), UT, Salt Lake City, 21 February 2018 - 25 February 2018, http://dx.doi.org/10.1016/j.bbmt.2017.12.357

Chinnabhandar V; Tran S; Sutton R; Shaw PJ; Mechinaud F; Cole C; Tapp H; Teague L; Fraser C; O'Brien TA; Mitchell R, 2018, 'Use of Thiotepa in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: An Australian and New Zealand Children's Haematology/Oncology Group Study', in Biology of Blood and Marrow Transplantation, Elsevier BV, Vol. 24, pp. S310 - S310, http://dx.doi.org/10.1016/j.bbmt.2017.12.357

Tyrrell V; Lau L; Arndt G; Barahona P; Cowley M; Ekert P; Failes T; Fletcher J; Gifford A; Haber M; Kamili A; Kumar A; Lock R; Marshall G; Mayoh C; Mead S; Mould E; O'Brien T; Pinese M; Khuong-Quang DA; Thomas D; Trahair T; Tsoli M; Tucker K; Wharby M; Wong M; Xie J; Ziegler D, 2018, 'Zero childhood cancer – Accelerating translation of experimental oncology: Better matching drug to target', in Pathology, Elsevier, Vol. 50, pp. s31, http://dx.doi.org/10.1016/j.pathol.2017.12.072

Bishop D; Xu N; Shen S; O'Brien T; Gottlieb D; Dolnikov A; Micklethwaite K, 2017, 'DIFFERING CO-STIMULATORY, LINKER AND SPACER DOMAINS PRODUCE VARIATIONS IN CD4 AND CD8 CELL COMPOSITION AND CYTOTOXIC POTENTIAL IN CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR19) T CELLS GENERATED WITH THE PIGGYBAC TRANSPOSASE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 19, pp. S10 - S10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399265400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fardell J; Donovan L; Wakefield C; Russell V; Mitchell R; O'Brien T; Ziegler D; Glenn M; Cohn R, 2016, 'Outcomes of Bereaved Parents Whose Child Did or Did not Participate in An Early Phase Clinical Trial', in PEDIATRIC BLOOD & CANCER, WILEY-BLACKWELL, Vol. 63, pp. S62 - S62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384818800579&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Robertson E; Fardell J; O'Brien T; Cohn R; Mitchell R; Drew D; Ziegler D; Marshall G; Wakefield C, 2016, 'Treatment Decision Making for Young People with Cancer and Their Parents', in PEDIATRIC BLOOD & CANCER, WILEY-BLACKWELL, Vol. 63, pp. S232 - S232, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384818801393&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Yang S; Shen S; Xu N; Chaudhry K; Nordon R; O'Brien T, 2016, 'PROLONGING CART CELL PERSISTENCE USING CONDITIONING WITH 5-AZACYTIDINE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S61 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen S; Xu N; Yang S; O'Brien T; Dolnikov A, 2016, 'STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS TO TREAT CANCER', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen S; Dolnikov A; O'Brien T, 2016, 'USE OF HDACI AND PD-1/PD-LI BLOCKADE TO ENHANCE CYTOLYTIC ACTIVITY OF EX VIVO EXPANDED NK CELLS AGAINST NEUROBLASTOMA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Klamer G; Chitranjan A; Xu N; Shen S; Micklethwaite KP; Lock RB; O’Brien T, 2014, 'Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy', in Blood, American Society of Hematology, Vol. 124, pp. 5813, http://dx.doi.org/10.1182/blood.v124.21.5813.5813

Frith K; O'Brien T; Tangye S; Sutton R; Ziegler J; Gray P, 2014, 'XLP-Associated Cerebral Vasculitis Successfully Treated with Bone Marrow Transplant', in JOURNAL OF CLINICAL IMMUNOLOGY, SPRINGER/PLENUM PUBLISHERS, Prague, CZECH REPUBLIC, Vol. 34, pp. S241 - S241, presented at 16th Biennial Meeting of the European-Society-for-Immunodeficiencies, Prague, CZECH REPUBLIC, 29 October 2014 - 01 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000347389100212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dolnikov A; Chitranjan A; Shen S; Klamer G; O'Brien T, 2014, 'TESTING CAR-T CELL ACTIVITY IN HUMAN HEMATOCHIMERIC MOUSE MODEL WITH THE NORMAL RANGE OF ANTIGEN EXPRESSION NOT RESCTRICTED TO THE TUMOUR ONLY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 16, pp. S23 - S23, http://dx.doi.org/10.1016/j.jcyt.2014.01.072

Dolnikov A; Klamer G; Shen S; Chitranjan A; Carol H; Lock R; O'Brien T, 2014, 'Identifying the factors modulating the efficacy of car-t cell therapy', in Cytotherapy, Elsevier, Vol. 16, pp. s7, http://dx.doi.org/10.1016/j.jcyt.2014.01.015

Sylvie S; Xu N; Klamer G; O'Brien T; Dolnikov A, 2012, 'GSK3β Inhibition Promotes T Cell Reconstitution and Preserves Naive T Cell Phenotype in Bone Marrow Reconstituted Mice', in Blood, American Society of Hematology, Vol. 120, pp. 1890 - 1890, http://dx.doi.org/10.1182/blood.v120.21.1890.1890

Ko KH; Holmes T; Song EY; Palladinetti P; Nordon R; O'Brien TA; Dolnikov A, 2010, 'GSK-3BETA INHIBITION PROMOTES ENGRAFTMENT OF EX VIVO EXPANDED HEMATOPOIETIC STEM CELLS AND MODULATES GENE EXPRESSION', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, Vol. 38, pp. S52 - S52, presented at 39th Annual Scientific Meeting of the ISEH - Society-for-Hematology-and-Stem-Cells, AUSTRALIA, Melbourne, 15 September 2010 - 18 September 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281168900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Srivastava A; Kwedza R; Sangadi I; Stapleton B; Rushton S; O' Brien T, 2026, Implementation of the Reporting for Better Cancer Outcomes (RBCO) Program: A system-wide multi-organisational quality improvement initiative in NSW, Australia, http://dx.doi.org/10.2139/ssrn.6991878

Westbrook J; Li L; Raban M; Mumford V; Badgery-Parker T; Gates P; Fitzpatrick E; Merchant A; Woods A; Baysari M; McCullagh C; Day R; Gazarian M; Dickinson M; Seaman K; Dalla-Pozza L; Ambler G; Barclay P; Gardo A; O'Brien T; Barbaric D; White L, Immediate and long-term effects of an electronic medication management system on paediatric prescribing errors: A stepped-wedge cluster randomised controlled trial with one-year follow-up, http://dx.doi.org/10.21203/rs.3.rs-2083575/v1

Robertson EG; Wakefield CE; Cohn RJ; O'Brien T; Ziegler DS; Fardell JE, The development of Delta: Using Agile to develop a decision aid for pediatric oncology clinical trial enrolment, http://dx.doi.org/10.2196/preprints.9258

Back to profile page